REGN icon

Regeneron Pharmaceuticals (REGN)

NASDAQ

$781.47

$10.78 (

+1.40%

)

1D
5D
1M
6M
1Y
5Y
Market closed

REGN: $781.47 / ₿ 0.0119 BTC / 1187699 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$770.69
$476.49 - $821.11
$82.62B
295.66
$764.48
$726,384.21
105.72M
18.58
$439.18 - $1,145.70
0.49
$763.42 - $786.32
Yes

What is Regeneron Pharmaceuticals (REGN)?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

The Regeneron Pharmaceuticals (REGN) stock price has been rising

The Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock price today is $781.47, reflecting a +1.40% move since the market opened. The company’s market capitalization stands at $82.62B, with a daily trading volume of $726.38K shares. For investors tracking price trends, Regeneron Pharmaceuticals, Inc. Common Stock stock has ranged between $763.42 and $786.32 today. The previous closing price was $770.69.

Get started with Regeneron Pharmaceuticals (REGN)

Ready to get started? Follow the steps below, or read our guide on how to buy Regeneron Pharmaceuticals stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy REGN

Search for REGN in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy REGN.

REGN FAQs

REGN is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

REGN is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Regeneron Pharmaceuticals, Inc. Common Stock (REGN) has traded between a low of $476.49 and a high of $821.11.

REGN is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

REGN’s payout ratio is 0.08. Payout ratio is a financial metric used to measure the proportion of a company's earnings that are paid out as dividends to shareholders.

REGN’s trailing dividend yield is 0.45999999999999996. Trailing dividend yield is a financial metric used to measure the return on investment from a company's dividend payments over the past 12 months.

Want to invest in Regeneron Pharmaceuticals? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
REGN icon
REGN

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Regeneron Pharmaceuticals in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.